IP Library › Granted Patent US 12,502,526
Granted Patent B2
US 12,502,526 · App. 17/530,318 · Granted Dec 23, 2025

Delivery of electromagnetic charge to muscles

Inventors: George Frangineas, Jr. (Fremont, CA); Like Zeng (Pleasanton, CA); Joel N. Jimenez Lozano (Pleasanton, CA)
Assignee: Zeltiq Aesthetics, Inc.
A61N1/0452A61N1/36003A61N1/3603A61N1/36132A61N1/36139A61N1/36153A61N1/36157A61N2/002A61N2/02A61N1/3787
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,502,526
App. No.
17/530,318
Granted
Dec 23, 2025
Kind
B2
Abstract

Systems and methods can be implemented in which an electromagnetic charge is used to strengthen, tone, and firm muscle tissues. For example, a magnetic muscle stimulation device may be provided that includes a processor and a device applicator having a housing and a coil positioned within in the housing. The processor may be configured to receive parameters for operation of the device applicator, and to cause, based on the received parameters, an alternating current to flow through the coil to generate a time-varying magnetic field that induces an integrated electric charge or electrical conductivity in a portion of tissue under a skin surface of a patient.

Claims (36)

1 . A magnetic muscle stimulation device for strengthening, toning, and firming muscle tissues, the magnetic stimulation device comprising:

a device applicator comprising a housing having a substantially flat applicator surface, and a coil positioned in the housing with an axis of the coil substantially perpendicular to the applicator surface; and

a processor configured to:

receive parameters for operation of the device applicator; and

direct, based on the received parameters, a pulse generating circuit to generate an alternating current to flow through the coil at a frequency equal to or greater than 30 Hz and a duty cycle equal to or greater than 35% thereby generating a time-varying magnetic field that induces an integrated electric charge/electrical conductivity, per pulse, of between 0.115 millivolt second meters (mV*s*m) to 0.75 mV*s*m across a half plane of muscle tissue having a side edge which is beneath a center of the coil and which is about 140 mm wide and extending to about 100 mm below a skin surface of a patient in a direction substantially orthogonal to the skin surface when the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

2 . The magnetic muscle stimulation device of claim 1 , wherein the processor is configured to, when the parameters are programmed to one or more set values, direct the pulse generating circuit to generate the integrated electric charge/electrical conductivity to be at least 0.14 mV*s*m in the muscle tissue under the skin surface of the patient when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

3 . The magnetic muscle stimulation device of claim 1 , wherein the processor is configured to, when the parameters are programmed to one or more set values, direct the pulse generating circuit to generate the integrated electric charge/electrical conductivity to be at least 0.15 mV*s*m in the muscle tissue under the skin surface of the patient when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

4 . The magnetic muscle stimulation device of claim 1 , wherein the alternating current includes a plurality of pulses at a predetermined frequency, and the processor is configured to, when the parameters are programmed to one or more set values, direct the pulse generating circuit to generate the time-varying magnetic field to induce a pulse charge of between 6.4 micro-coulombs (μC) to 10 μC across a portion within the half plane of muscle tissue for each pulse of the alternating current when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient, wherein the portion within the half plane extends between 22 and 37 mm beneath the skin surface.

5 . The magnetic muscle stimulation device of claim 1 , wherein the processor is configured to, when the parameters are programmed to one or more set values, direct the pulse generating circuit to generate the integrated electric charge to induce a triphasic muscle stimulation in the muscle tissue of the patient when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

6 . The magnetic muscle stimulation device of claim 1 , wherein the processor is configured to, when the parameters are programmed to one or more set values, direct the pulse generating circuit to generate an induced maximum current, peak to peak, of between 70 milliamps (mA) to 200 mA in the muscle tissue of the patient when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

7 . The magnetic muscle stimulation device of claim 1 , wherein the processor is configured to, when the parameters are programmed to one or more set values, direct the pulse generating circuit to generate a maximum current density norm of between 40 amps per meter squared (A/m 2 ) to 100 A/m 2 in the muscle tissue of the patient when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

8 . The magnetic muscle stimulation device of claim 1 , wherein the frequency is selected from the group consisting of 30, 35, 40, 45, and 50 Hz.

9 . The magnetic muscle stimulation device of claim 1 , wherein the alternating current has a pulse width of approximately 300 to 450 microseconds (μS) for the alternating current when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

10 . The magnetic muscle stimulation device of claim 1 , wherein the alternating current has a sinusoidal, biphasic waveform when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

11 . The magnetic muscle stimulation device of claim 1 , wherein the alternating current has an amplitude of approximately 2000 amps when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

12 . The magnetic muscle stimulation device of claim 1 , wherein the time-varying magnetic field has a maximum magnetic flux density of approximately 1.3 to 1.4 Tesla (T) at the applicator surface when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

13 . The magnetic muscle stimulation device of claim 1 , wherein the pulse generating circuit includes one or more switching devices and at least one capacitor with a rated voltage of approximately 1300-1700 volts and a rated capacitance of approximately 70-110 microfarads.

14 . The magnetic muscle stimulation device of claim 1 , further comprising a cooling system configured to provide a liquid coolant for thermally cooling the coil of the applicator, and

wherein the housing comprises a cooling chamber at least partially surrounding the coil and configured to be at least partially filled with the liquid coolant provided by the cooling system, the liquid coolant cooling the applicator surface below an operating temperature of the coil when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

15 . The magnetic muscle stimulation device of claim 1 , further comprising a barrier cover removably attached to the housing to prevent contact of the applicator surface to the skin surface of the patient.

16 . A method for strengthening, toning, and firming muscle tissues, the method comprising:

receiving parameters for operation of a magnetic muscle stimulation device comprising a device applicator having a coil positioned in a housing of the device applicator, an axis of the coil substantially perpendicular to an applicator surface of the housing; and

directing, based on the received parameters, a pulse generating circuit to generate an alternating current to flow through a coil of the magnetic muscle stimulation device at a frequency between 30 Hz to 50 Hz and a duty cycle equal to or greater than 35% thereby generating a time-varying magnetic field that induces an integrated electric charge/electrical conductivity, per pulse, of between 0.115 millivolt second meters (mV*s*m) to 0.75 mV*s*m across a half plane of muscle tissue having a side edge which is beneath a center of the coil and which is about 140 mm wide and extending to about 100 mm below a skin surface of a patient in a direction substantially orthogonal to the skin surface when the applicator surface of the magnetic muscle stimulation device is positioned substantially on and parallel to the skin surface of the patient; and

wherein the method is performed by one or more processors.

17 . The method of claim 16 , further comprising:

receiving one or more parameter values for defining the integrated electric charge/electrical conductivity as being between 0.14 mV*s*m to 0.75 mV*s*m in the muscle tissue under the skin surface of the patient; and

directing, based on the received one or more parameter values, the pulse generating circuit to generate the integrated electric charge/electrical conductivity to be between 0.14 mV*s*m to 0.75 mV*s*m in the muscle tissue under the skin surface of the patient when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

18 . The method of claim 16 , further comprising:

receiving one or more parameter values for defining the integrated electric charge/electrical conductivity as being between 0.15 mV*s*m to mV*s*m in the muscle tissue under the skin surface of the patient; and

directing, based on the received one or more parameter values, the pulse generating circuit to generate the integrated electric charge/electrical conductivity to be between 0.15 mV*s*m to 0.75 mV*s*m in the muscle tissue under the skin surface of the patient when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient.

19 . The method of claim 16 , further comprising:

receiving one or more parameter values for defining, for each pulse of the alternating current, a pulse charge of between 6.4 micro-coulombs (μC) to 10 μC in the muscle tissue of the patient; and

directing, based on the received one or more parameter values, the pulse generating circuit to generate the time-varying magnetic field to induce a pulse charge of between 6.4 micro-coulombs (μC) to 10 μC across a portion within the half plane of muscle tissue for each pulse of the alternating current when the alternating current is flowing through the coil and the applicator surface is positioned substantially on and parallel to the skin surface of the patient, wherein the portion within the half plane extends between 22 and 37 mm beneath the skin surface.

20 . A non-transitory computer-readable medium comprising a plurality of instructions that, when read by a computing system, causes the computing system to perform a method of strengthening, toning, and firming muscle tissues, the method comprising:

receiving parameters for operation of a magnetic muscle stimulation device comprising a device applicator having a coil positioned in a housing of the device applicator, an axis of the coil substantially perpendicular to an applicator surface of the housing; and

directing, based on the received parameters, a pulse generating circuit to generate an alternating current to flow through a coil of the magnetic muscle stimulation device at a frequency between 30 Hz to 50 Hz and a duty cycle equal to or greater than 35% thereby generating a continuously pulsed time-varying magnetic field that induces an integrated electric charge/electrical conductivity, per pulse, of between 0.115 millivolt second meters (mV*s*m) to 0.75 mV*s*m across a half plane of muscle tissue having a side edge which is beneath a center of the coil and which is about 140 mm wide and extending to about 100 mm below a skin surface of a patient when an applicator surface of the magnetic muscle stimulation device is positioned substantially on and parallel to the skin surface of the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2022
From: FRANGINEAS, GEORGE, JR.; ZENG, LIKE; JIMENEZ LOZANO, JOEL N.
To: ZELTIQ AESTHETICS, INC.
Reel/Frame 059932/0724 →
Continuity (2)
Provisional Application 63116154 · Nov 19, 2020
Related Publication 20220152379A1 · May 19, 2022
References Cited (25)
US 10471269B1 · Schwarz et al. · 2019 [cited by applicant]
US 10478634B2 · Schwarz et al. · 2019 [cited by applicant]
US 10493293B2 · Schwarz et al. · 2019 [cited by applicant]
US 10556122B1 · Schwarz et al. · 2020 [cited by applicant]
US 10632321B2 · Schwarz et al. · 2020 [cited by applicant]
US 10688310B2 · Schwarz et al. · 2020 [cited by applicant]
US 10695575B1 · Schwarz et al. · 2020 [cited by applicant]
US 10695576B2 · Schwarz et al. · 2020 [cited by applicant]
US 10709894B2 · Schwarz et al. · 2020 [cited by applicant]
US 10709895B2 · Schwarz et al. · 2020 [cited by applicant]
US 11266852B2 · Schwarz et al. · 2022 [cited by applicant]
US 11464994B2 · Schwarz et al. · 2022 [cited by applicant]
US 11497925B2 · Schwarz et al. · 2022 [cited by applicant]
US 11590356B2 · Schwarz et al. · 2023 [cited by applicant]
US 11691024B2 · Schwarz et al. · 2023 [cited by applicant]
US 11794029B2 · Schwarz et al. · 2023 [cited by applicant]
US 20150157873A1 · Sokolowski · 2015 [cited by applicant]
US 20160151637A1 · Abe et al. · 2016 [cited by applicant]
US 20180001107A1 · Schwarz et al. · 2018 [cited by applicant]
US 20190201706A1 · Schwarz et al. · 2019 [cited by applicant]
US 20200001103A1 · Schwarz · 2020 [cited by examiner]
DE 202016008804U1 · 2019 [cited by applicant]
JP 2015107176A · 2015 [cited by applicant]
JP 2015521879A · 2015 [cited by applicant]
WO WO2018136431A1 · 2018 [cited by applicant]
Cited By (1)
US 1,133,185